Home
News
In Focus
Business
Metro
Nation
World
Sports
Feature
Opinion
View more »Opinion Columns
Wan LixinOpinion deputy editor of Shanghai Daily
Restaurants get off to a quick start thanks to game-changing policies
High service charges on event ticket refunds call for further regulation
Sunday
- Subscribe
Related News
Higher medical bills hit health insurer
Source: Agencies |
July 28, 2009, Tuesday
|
Print Edition
Print Edition
HEALTH insurer Aetna Inc said yesterday its profit fell 28 percent in the second quarter due to higher medical expenses in its commercial business.
The United States company said it earned US$346.6 million, or 77 cents per share, compared with US$480.5 million, or 97 cents per share, a year earlier. Adjusted earnings per share were 68 cents. Revenue grew 11 percent to US$8.67 billion from US$7.83 billion.
Aetna said its medical benefit ratio, which measures the portion of premium dollars spent on providing care, rose to 86.8 percent from 81.9 percent a year ago.
Premium revenue grew 12 percent and medical membership was flat at 19.1 million.
Aetna said commercial medical costs increased due to the use of more expensive services, and more tests and procedures per visit. That led to higher costs for emergency room, urgent care, laboratory and preventive services.
Aetna said its prices did not fully account for the higher costs, and said health-plan providers are changing their behavior due to the recession.
It cut its annual profit forecast for the second time in two months. The company now expects to earn between US$2.75 to US$2.90 per share. On June 2, it lowered its profit estimate to a range of US$3.55 to US$3.70 per share, also because of greater commercial medical costs and lower Medicare revenue.
Aetna expects to spend between 84 and 84.5 percent of its commercial premium revenue on providing medical care.
The Wall Street Journal reported yesterday that Aetna is planning to sell its pharmacy benefits management business, which had about 11.2 million members at the end of the second quarter.
According to the report, independent pharmacy benefits managers CVS Caremark Corp and Medco Health Solutions Inc have looked into buying the business.
The United States company said it earned US$346.6 million, or 77 cents per share, compared with US$480.5 million, or 97 cents per share, a year earlier. Adjusted earnings per share were 68 cents. Revenue grew 11 percent to US$8.67 billion from US$7.83 billion.
Aetna said its medical benefit ratio, which measures the portion of premium dollars spent on providing care, rose to 86.8 percent from 81.9 percent a year ago.
Premium revenue grew 12 percent and medical membership was flat at 19.1 million.
Aetna said commercial medical costs increased due to the use of more expensive services, and more tests and procedures per visit. That led to higher costs for emergency room, urgent care, laboratory and preventive services.
Aetna said its prices did not fully account for the higher costs, and said health-plan providers are changing their behavior due to the recession.
It cut its annual profit forecast for the second time in two months. The company now expects to earn between US$2.75 to US$2.90 per share. On June 2, it lowered its profit estimate to a range of US$3.55 to US$3.70 per share, also because of greater commercial medical costs and lower Medicare revenue.
Aetna expects to spend between 84 and 84.5 percent of its commercial premium revenue on providing medical care.
The Wall Street Journal reported yesterday that Aetna is planning to sell its pharmacy benefits management business, which had about 11.2 million members at the end of the second quarter.
According to the report, independent pharmacy benefits managers CVS Caremark Corp and Medco Health Solutions Inc have looked into buying the business.
- About Us
- |
- Terms of Use
- |
-
RSS - |
- Privacy Policy
- |
- Contact Us
- |
- Shanghai Call Center: 962288
- |
- Tip-off hotline: 52920043
- 沪ICP证：沪ICP备05050403号-1
- |
- 互联网新闻信息服务许可证：31120180004
- |
- 网络视听许可证：0909346
- |
- 广播电视节目制作许可证：沪字第354号
- |
- 增值电信业务经营许可证：沪B2-20120012
Copyright © 1999- Shanghai Daily. All rights reserved.Preferably viewed with Internet Explorer 8 or newer browsers.
